La guía 2016 sobre interacciones entre medicamentos psicotrópicos
Dr. C. Lindsay DeVane y Dr. Charles B. Nemeroff
EDITOR’S LETTER
Charles B. Nemeroff, MD, PhD
La guía 2016 sobre interacciones entre medicamentos psicotrópicos, Part 2
C. Lindsay DeVane, PharmD y Charles B. Nemeroff, MD, PhD
Neuropharmacology of Paroxetine
By Michael J. Owens, PhD, and Charles B. Nemeroff, MD, PhD
Remission: Today’s Target in the Treatment of Mood and Anxiety Disorders
By Charles B. Nemeroff, MD, PhD
New Developments in Depression and Anxiety Disorders
Advancing the Treatment of Mood and Anxiety Disorders: The First 10 Years’ Experience with Paroxetine
Pharmacology of Valproate
Advancing the Treatment of Anxiety Disorders: New Findings and Novel Uses for Atypical Antipsychotics
Early-Life Adversity, CRF Dysregulation, and Vulnerability to Mood and Anxiety Disorders
Drug Development for Anxiety Disorders: New Roles for Atypical Antipsychotics
By William H. Carson, MD, Hisashi Kitagawa, PhD, and Charles B. Nemeroff, MD, PhD